Cytomed Therapeutics Limited (GDTC) Stock Price, Quote & News

Company Profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a plu...

Industry: Biotechnology

Sector: Healthcare

Phone: 65 6250 7738

Website: w2.cytomed.sg

Address:

1 Commonwealth Lane, No. 08-22, Singapore, Singapore

kshonstocks Jun. 18 at 5:15 PM

$GDTC turning on chart keep an eye on it

0 · Reply

topstockalerts Apr. 10 at 1:26 PM

$GDTC premarket move..

0 · Reply

topstockalerts Apr. 10 at 11:25 AM

Pre Market Top Gainers PT2 $HYFM $HLP $GNFT $ATXS $GDTC

0 · Reply

KingCornbread8853 Mar. 31 at 4:22 PM

$GDTC

0 · Reply

KingCornbread8853 Feb. 21 at 5:07 PM

$GDTC

0 · Reply

Zerynx Feb. 6 at 12:43 PM

$GDTC great future ahead for this company. https://www.globenewswire.com/news-release/2025/02/06/3021922/0/en/CytoMed-Therapeutics-announces-Chairman-s-Letter-to-the-Company-s-shareholders.html

0 · Reply

Chevygirl1975 Feb. 5 at 1:43 PM

$TNXP okay. $TNXP looks like toast. Nice 6 month chart for $GDTC though. Just saying. It's not a day trade, it looks steady.

0 · Reply

Zerynx Feb. 4 at 6:14 PM

$GDTC

0 · Reply

Zerynx Jan. 25 at 3:55 PM

$GDTC this will be big once their phase 2 clinical trial yields positive results.

0 · Reply

monkeysun Jan. 20 at 5:29 PM

$FGI $TENX $GDTC $NISN $ABVE

0 · Reply

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Feb 6, 2025, 7:20 AM EST - 4 months ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Jan 6, 2025, 11:10 AM EST - 6 months ago

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Aug 20, 2024, 7:00 AM EDT - 11 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

Jul 17, 2024, 7:00 AM EDT - 1 year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Mar 20, 2024, 8:30 AM EDT - 1 year ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 18, 2024, 6:00 AM EDT - 1 year ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 4, 2024, 5:00 AM EST - 1 year ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Jan 29, 2024, 7:00 AM EST - 1 year ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 1 year ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Nov 17, 2023, 9:21 AM EST - 1 year ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 14, 2023, 7:47 AM EST - 1 year ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Oct 24, 2023, 1:00 PM EDT - 1 year ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 1 year ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 1, 2023, 8:00 PM EDT - 1 year ago

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

Aug 29, 2023, 9:00 AM EDT - 1 year ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 20, 2023, 3:50 AM EDT - 2 years ago

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

ARQT SMMT

Aug 17, 2023, 7:30 AM EDT - 2 years ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 15, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 1, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 6, 2023, 7:00 AM EDT - 2 years ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

May 11, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 9, 2023, 10:07 AM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

Apr 13, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 7, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

ARBB ATMU GDHG GMM ISPR KVUE MGIH

Feb 3, 2023, 5:46 PM EST - 2 years ago

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO

kshonstocks Jun. 18 at 5:15 PM

$GDTC turning on chart keep an eye on it

0 · Reply

topstockalerts Apr. 10 at 1:26 PM

$GDTC premarket move..

0 · Reply

topstockalerts Apr. 10 at 11:25 AM

Pre Market Top Gainers PT2 $HYFM $HLP $GNFT $ATXS $GDTC

0 · Reply

KingCornbread8853 Mar. 31 at 4:22 PM

$GDTC

0 · Reply

KingCornbread8853 Feb. 21 at 5:07 PM

$GDTC

0 · Reply

Zerynx Feb. 6 at 12:43 PM

$GDTC great future ahead for this company. https://www.globenewswire.com/news-release/2025/02/06/3021922/0/en/CytoMed-Therapeutics-announces-Chairman-s-Letter-to-the-Company-s-shareholders.html

0 · Reply

Chevygirl1975 Feb. 5 at 1:43 PM

$TNXP okay. $TNXP looks like toast. Nice 6 month chart for $GDTC though. Just saying. It's not a day trade, it looks steady.

0 · Reply

Zerynx Feb. 4 at 6:14 PM

$GDTC

0 · Reply

Zerynx Jan. 25 at 3:55 PM

$GDTC this will be big once their phase 2 clinical trial yields positive results.

0 · Reply

monkeysun Jan. 20 at 5:29 PM

$FGI $TENX $GDTC $NISN $ABVE

0 · Reply

Brence04 Jan. 17 at 5:52 PM

$GDTC 🔥 $3 soon

0 · Reply

alentejano Jan. 16 at 8:23 PM

$GDTC on my opinion looking for the chart 4H is starting to reverse

0 · Reply

shameeza Jan. 16 at 6:47 PM

$GDTC This board is very quiet

1 · Reply

MarketMasterMind Jan. 14 at 11:46 AM

$GDTC adding some 🤑Ⓜ️

0 · Reply

topstockalerts Jan. 13 at 2:13 PM

Pre Market Top Gainers PT2 $XHG $GDTC $GCTK $XFOR $ATEX

0 · Reply

Looseforwin Jan. 13 at 9:33 AM

$GDTC suprise? With how many shares?

0 · Reply

NextBigRun Jan. 12 at 5:03 AM

All eyes 👀 on ticker ﹩MCVT - The only stock in the sector with no dilution and this low of a market cap. They have many incoming milestones to be accomplished in 2025. Now crossed with a short squeeze, all retail needs to unite and this can be the next 10x runner! 🚨 Trump is going to help small companies and those same companies need companies like MCVT. There is a lot of due diligence on this name supporting a 100m market cap one day. https://www.youtube.com/watch?v=uOzGYjSyzWs $MNTS $GDTC $ZPTA $ADN $AYRO !! ! ! ! watch these 5 too

0 · Reply

Bullbear1010101 Jan. 11 at 12:00 AM

$GDTC

0 · Reply

VrtcIl Jan. 10 at 7:37 PM

Momentum continuing in $GDTC and heading for 3. Keep and eye on bigger highs and lows. The trend structure should remain stable, otherwise take some risk off. Price: 2.88 Float: 4.1M Short Float: 1.3 % 💰 Dollar Volume: 1.7K ℹ️ Singapore | Biotechnology

1 · Reply

Zerynx Jan. 10 at 6:24 PM

$GDTC expecting the clinical trials to have positive results. Great medium to long term stock to get in on while it's at a discount.

1 · Reply

Market Cap	24.34M
Revenue (ttm)	50,000.00
Net Income (ttm)	-1.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,680.00%
Debt to Equity Ratio	0.05

Volume	1,600
Avg Vol	11,512
Day's Range	N/A - N/A
Shares Out	10.94M
Stochastic %K	97%
Beta	-0.33
Analysts	Sell
Price Target	$5.00